Switch to: References

Add citations

You must login to add citations.
  1. Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews.Nothando Ngwenya, Collins Iwuji, Nabeel Petersen, Nompilo Myeni, Samukelisiwe Nxumalo, Ursula Ngema & Janet Seeley - 2022 - Journal of Medical Ethics 48 (10):712-717.
    Purpose We examine the levels of post-trial responsibility ascribed to different stakeholders, following a community-based clinical trial and how the ‘responsibility’ is understood. Methods We employed photovoice, unstructured observations and key informant interviews to gain insights into contexts of access to care following transition to the public health system post trial. We used an inductive narrative analysis to explore experiences and understandings of post-trial access. Results In their photovoice stories, many participants expressed a sense of abandonment after the trial. This (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management.J. Lawton, M. Blackburn, D. Rankin, C. Werner, C. Farrington, R. Hovorka & N. Hallowell - 2019 - AJOB Empirical Bioethics 10 (2):100-112.
    Increasing ethical attention and debate is focusing on whether individuals who take part in clinical trials should be given access to post-trial care. However, the main focus of this debate has been upon drug trials undertaken in low-income settings. To broaden this debate, we report findings from interviews with individuals (n = 24) who participated in a clinical trial of a closed-loop system, which is a medical device under development for people with type 1 diabetes that automatically adjusts blood glucose (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Mechanisms for sustainable post-trial access: A perspective.P. Naidoo & V. Rambiritch - 2021 - South African Journal of Bioethics and Law 14 (3):77-78.
    Clinical trials are essential to establish the safety and efficacy of investigational products, contributing to risk/benefit assessments that ultimately determine whether these products meet the criteria for market authorisation. Clinical trials are also an important source of revenue and expertise generation for countries in which they are conducted. In developing countries, they represent substantial foreign direct investment. In spite of the substantial capital input that clinical trials require, the issue of funding post-trial access to beneficial therapies remains contentious, especially in (...)
    Download  
     
    Export citation  
     
    Bookmark